Interstitial Lung Disease Associated with Connective Tissue Diseases.

Area of Science:

• Pulmonology
• Rheumatology
• Immunology

Background:

• Connective tissue disease-interstitial lung disease (CTD-ILD) presents significant morbidity and mortality.
• Interstitial lung disease (ILD) is a serious pulmonary manifestation of CTD.
• Prompt immunosuppressive therapy can alter the natural course of CTD-ILD, improving survival.

Purpose of the Study:

• To highlight the importance of early identification and treatment of CTD-ILD.
• To differentiate CTD-ILD from idiopathic pulmonary fibrosis (IPF).
• To introduce the concept and utility of interstitial pneumonia with autoimmune features (IPAF).

Main Methods:

• Clinical assessment, including serological and morphologic features.
• Multidisciplinary team evaluation.
• Histopathological analysis for differential diagnosis.

Main Results:

• CTD-ILD generally has a better prognosis than IPF due to response to immunosuppressants.
• Nonspecific interstitial pneumonia (NSIP) is the most common CTD-ILD subtype, distinct from IPF's usual interstitial pneumonia (UIP) pattern.
• Rheumatoid arthritis is an exception, often presenting with UIP.

Conclusions:

• Early recognition and treatment of CTD-ILD are vital for better outcomes.
• Accurate differentiation between IPF and CTD-ILD is necessary, as IPF may lack typical UIP features.
• Identifying IPAF aids in managing ILD patients with autoimmune features who may benefit from immunosuppression.